Fulltext

Diagnostic Performance of (68)Ga-DOTATATE PET/CT, (18)F-FDG PET/CT and (131)I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma

Tan TH 1 , Hussein Z 2 , Saad FF 3 , Shuaib IL 4

Affiliations 

  • 1 Nuclear Medicine Department, National Cancer Institute, No 4, Jalan P7, Presint 7, 62550 Putrajaya, Malaysia
  • 2 Department of Endocrine, Hospital Putrajaya, Presint 7, 62250 Putrajaya, Wilayah Persekutuan Malaysia
  • 3 Department of Diagnostic Imaging, Serdang Hospital, Jalan Puchong, Serdang, 43000 Malaysia
  • 4 Department of Radiology, Advanced Medical and Dental Institute, University Sains Malaysia, Bertam, 13200 Kepala Batas, Pulau Pinang Malaysia
Nucl Med Mol Imaging, 2015 Jun;49(2):143-51.
PMID: 26085860 DOI: 10.1007/s13139-015-0331-7

Abstract

To evaluate the diagnostic performance of (68)Ga-DOTATATE (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT), (18)F-FDG PET/CT and (131)I-MIBG scintigraphy in the mapping of metastatic pheochromocytoma and paraganglioma.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications